NIA-AA Symposium: Developing an Applied Science of Recruitment and Retention for Alzheimer’s Disease and Related Dementia (AD/ADRD) Clinical Research
Live session: Friday, July 31, 2020 at 11:30 a.m. Central Standard Time
Investing in and prioritizing research to study the effectiveness of Alzheimer’s disease clinical study recruitment strategies, support program evaluation and disseminate best practices is critical to developing an applied science of recruitment. Public and private research funding agencies, academic institutions and researchers globally have an important role in evaluating the effectiveness of their own strategies, making transparent their research methodology, and sharing results broadly and promptly. Globally, agencies and national advocacy organizations can help develop, collect and widely disseminate research-based best practices.
This AAIC event comes at an important time in the ongoing partnership between scientists and the public to find more effective ways to prevent, diagnose and treat Alzheimer’s disease and related dementias (AD/ADRD). There is now an unprecedented opportunity to build on scientific knowledge and to accelerate and expand the research effort around recruitment strategies, and it is incumbent upon all of us to leverage our different missions, interests and resources to meet this critical need. The goal of this preconference is to provide us a global perspective that will help build a strong scientific foundation for the science of recruitment around AD/ADRD clinical trials.
Through this AAIC event, we will provide a global forum to make progress toward this important goal. We aim to identify opportunities to accelerate and expand existing efforts and discuss novel approaches, including building new collaborations and partnerships. While we can support and incentivize improved recruitment in several ways, successfully developing an applied science of recruitment requires involvement and contributions from a diverse range of stakeholders, including those involved in funding, regulating, guiding or using outcomes from research. This might include:
Specific objectives of the meeting include:
This session is open to international experts and practitioners invested or interested in participant recruitment to Alzheimer’s Disease and Related Dementias (AD/ADRD) clinical trials.
Go beyond the conference — network and collaborate year-round with a global community of leaders who are working to advance Alzheimer’s and dementia research.